Vergelijking

Buserelin vs. Epitalon

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

57982-77-1

307297-39-8

Molecuulmassa

1239.42 g/mol

390.35 g/mol

Halfwaardetijd

geen gegevens

0.3 h

Sequentie

geen gegevens

Ala-Glu-Asp-Gly

Werkingsmechanisme

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Epitalon

Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.

Bewijsbasis

Hoogste bewijs

Humane RCT

Humane studie

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Buserelin	Epitalon
Duitsland	Op recept	Niet goedgekeurd
RU	—	Alleen onderzoek
Verenigde Staten	Niet goedgekeurd	Niet goedgekeurd

Volledige vermeldingen

Buserelin

Volledige vermelding →

Epitalon

Volledige vermelding →

Frequently asked questions

What is the difference between Buserelin and Epitalon?: Buserelin is classified as "Onderzoek (overig)", while Epitalon is classified as "Onderzoek (overig)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Epitalon?: The highest available evidence level is "Humane RCT" for Buserelin and "Humane studie" for Epitalon. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Epitalon in Germany and the United States?: Duitsland: Buserelin — Op recept, Epitalon — Niet goedgekeurd. Verenigde Staten: Buserelin — Niet goedgekeurd, Epitalon — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Epitalon

Duitsland

Op recept

Niet goedgekeurd

—

Alleen onderzoek

Verenigde Staten

Niet goedgekeurd

Frequently asked questions

What is the difference between Buserelin and Epitalon?

Buserelin is classified as "Onderzoek (overig)", while Epitalon is classified as "Onderzoek (overig)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Epitalon?

The highest available evidence level is "Humane RCT" for Buserelin and "Humane studie" for Epitalon. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Epitalon in Germany and the United States?

Duitsland: Buserelin — Op recept, Epitalon — Niet goedgekeurd. Verenigde Staten: Buserelin — Niet goedgekeurd, Epitalon — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.